# BioCentury

Source: https://onco.cc/collections/src-biocentury/  
OnCo record `src-biocentury` (Collection). Data CC BY-NC 4.0, attribute "Data from OnCo (onco.cc)"; commercial use needs a licence.

## TL;DR

BioCentury writes analysis for people who make decisions about pipelines.

## Summary

BioCentury writes strategic analysis of biopharma for people who make decisions about pipelines: regulatory trends, first-in-class approvals, China and deal terms. It publishes daily, and its monthly first-in-class approval tallies and its regulatory reform coverage are distinctive among the industry titles. Access is by subscription, so most of the analysis sits behind a paywall. On OnCo it is listed as a source with the tags source and news, read for the pipeline-level and regulatory view of oncology rather than for individual trial results.

## Fields

- Kind: Collection
- Last checked: 2026-09-08
- Tags: source; news
- URL: https://www.biocentury.com/
- Holds: Strategic analysis of biopharma: regulatory trends, first-in-class approvals, China, deal terms.
- Licence: Subscription

## Sources

- BioCentury: https://www.biocentury.com/

## Connected records

- collections: [Endpoints News](https://onco.cc/collections/src-endpoints-news/), [Evaluate Vantage](https://onco.cc/collections/src-evaluate/)

---
JSON: https://onco.cc/api/v1/entities/src-biocentury.json